Catalin Codreanu
Overview
Explore the profile of Catalin Codreanu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
2447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Georgiadis S, Pons M, Rasmussen S, Hetland M, Linde L, Di Giuseppe D, et al.
RMD Open
. 2025 Feb;
11(1).
PMID: 39979039
Objectives: We aimed to compare various methods for imputing disease activity in longitudinally collected observational data of patients with axial spondyloarthritis (axSpA). Methods: We conducted a simulation study on data...
2.
Pons M, Georgiadis S, Hetland M, Faizy Ahmadzay Z, Rasmussen S, Christiansen S, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892891
Objective: In patients with axial spondyloarthritis (axSpA) initiating secukinumab (SEC), we aimed to identify baseline (treatment start) predictors of achieving low disease activity (LDA) after 6 months, as measured by...
3.
Ciurea A, Kissling S, Gotschi A, Ornbjerg L, Rasmussen S, Tamasi B, et al.
Arthritis Res Ther
. 2025 Jan;
27(1):18.
PMID: 39891200
Background: Efficacy of tumour necrosis factor inhibitors (TNFi) for peripheral arthritis in patients with psoriatic arthritis (PsA) has been established in randomized clinical trials that have used improvement in summated...
4.
Ahmadzay Z, Heberg J, Jorgensen J, Ornbjerg L, Ostergaard M, Moller-Bisgaard S, et al.
Rheumatol Adv Pract
. 2024 Nov;
8(4):rkae135.
PMID: 39611201
Objectives: Real-world evidence is needed to inform treatment strategies for patients with PsA and axial SpA (axSpA) who have non-musculoskeletal manifestations (NMMs), various risk factors and comorbidities. International collaboration is...
5.
Pons M, Georgiadis S, Ostergaard M, Faizy Ahmadzay Z, Glintborg B, Heberg J, et al.
Joint Bone Spine
. 2024 Nov;
92(3):105824.
PMID: 39608666
Objectives: In axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) patients initiating secukinumab, we aimed to assess retention rates and proportions of patients achieving remission and low disease activity (LDA), according...
6.
Agache M, Popescu C, Enache L, Mogosan C, Filippucci E, Codreanu C
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124833
In psoriatic arthritis (PsA), musculoskeletal ultrasound is a complementary tool to physical examination, useful even in patients in remission to detect subclinical activity. The objective of the study was to...
7.
Christiansen S, Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, et al.
RMD Open
. 2024 Jul;
10(3.
PMID: 39053949
Objectives: To compare the treatment effectiveness of secukinumab in radiographic (r) versus non-radiographic (nr) axial spondyloarthritis (axSpA) patients treated in routine care across Europe. Methods: Prospectively collected data on secukinumab-treated...
8.
Hellamand P, van de Sande M, Nurmohamed M, van Vollenhoven R, Hollick R, Rotariu O, et al.
Rheumatology (Oxford)
. 2024 Jul;
PMID: 39041780
Objectives: To investigate sex differences in patient-reported outcome measures (PROMs) among axSpA patients initiating their first TNFi and identify factors contributing to these disparities over the follow-up. Methods: Data were...
9.
Linde L, Georgiadis S, Ornbjerg L, Rasmussen S, Michelsen B, Askling J, et al.
Arthritis Care Res (Hoboken)
. 2024 Jun;
76(11):1558-1565.
PMID: 38926900
Objective: Because 66/68 joint counts are not always performed in routine care, we aimed to determine which of the modified 28-joint disease activity index for psoriatic arthritis (DAPSA28) or 28-joint...
10.
Ionescu C, Popescu C, Agache M, Dinache G, Codreanu C
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610822
The primary objective of this study was to estimate depression's prevalence in a cohort of rheumatoid arthritis (RA) patients, and the secondary objective was to evaluate the impact of depression...